A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk - Full Text View - ClinicalTrials.gov
In this line, the present work reports the short-term whole-body metabolic adaptations, spatio-temporal coordination of the organ-specific responses, and the contribution of each receptor to the metabolic effects of a dualAG, the latter being achieved in vivo by using antagonists or mAbs to avoid possible metabolic adaptations due to genetic deletion of Glp1r or Gcgr 39,40
Clin Med Insights Endocrinol Diab
J Gerontol A Biol Sci Med Sci (2015) 70(1):4452.10.1093/gerona/glu008 261 WuYLiuCSunHVijayakumarAGiglouPRQiaoRet alGrowth hormone receptor regulates beta cell hyperplasia and glucose-stimulated insulin secretion in obese mice
Studies have looked into its effects on glucose metabolism, insulin sensitivity and lipid metabolism with research suggesting benefits for metabolic dysfunction and fat accumulation patterns
Most trackers do shots and weight
